These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10448113)

  • 21. The molecular basis of lung cancer: molecular abnormalities and therapeutic implications.
    Massion PP; Carbone DP
    Respir Res; 2003; 4(1):12. PubMed ID: 14641911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumour biology: senescence in premalignant tumours.
    Collado M; Gil J; Efeyan A; Guerra C; Schuhmacher AJ; Barradas M; Benguría A; Zaballos A; Flores JM; Barbacid M; Beach D; Serrano M
    Nature; 2005 Aug; 436(7051):642. PubMed ID: 16079833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypermethylation of ASC/TMS1 is a sputum marker for late-stage lung cancer.
    Machida EO; Brock MV; Hooker CM; Nakayama J; Ishida A; Amano J; Picchi MA; Belinsky SA; Herman JG; Taniguchi S; Baylin SB
    Cancer Res; 2006 Jun; 66(12):6210-8. PubMed ID: 16778195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The significance of associated pre-invasive lesions in patients resected for primary lung neoplasms.
    Ruffini E; Bongiovanni M; Cavallo A; Filosso PL; Giobbe R; Mancuso M; Molinatti M; Oliaro A
    Eur J Cardiothorac Surg; 2004 Jul; 26(1):165-72. PubMed ID: 15200997
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early detection of lung cancer: clinical perspectives of recent advances in biology and radiology.
    Hirsch FR; Franklin WA; Gazdar AF; Bunn PA
    Clin Cancer Res; 2001 Jan; 7(1):5-22. PubMed ID: 11205917
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pre-cancerous lesions for colorectal cancers in rodents: a new concept.
    Yamada Y; Mori H
    Carcinogenesis; 2003 Jun; 24(6):1015-9. PubMed ID: 12807742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lung cancer: chemoprevention and intermediate effect markers.
    Tockman MS
    IARC Sci Publ; 2001; 154():257-70. PubMed ID: 11220665
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray.
    Maitra A; Adsay NV; Argani P; Iacobuzio-Donahue C; De Marzo A; Cameron JL; Yeo CJ; Hruban RH
    Mod Pathol; 2003 Sep; 16(9):902-12. PubMed ID: 13679454
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Molecular biology in the diagnosis of lung cancer].
    Haugen A
    Tidsskr Nor Laegeforen; 2005 Dec; 125(23):3283-5. PubMed ID: 16327855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methylated genes as new cancer biomarkers.
    Duffy MJ; Napieralski R; Martens JW; Span PN; Spyratos F; Sweep FC; Brunner N; Foekens JA; Schmitt M;
    Eur J Cancer; 2009 Feb; 45(3):335-46. PubMed ID: 19138839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Advances in the study of preneoplastic lesions of lung cancer].
    Wang GF; Lai MD
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Jan; 27(1):55-7. PubMed ID: 14989828
    [No Abstract]   [Full Text] [Related]  

  • 32. Pulmonary preneoplasia--sequential molecular carcinogenetic events.
    Lantuéjoul S; Salameire D; Salon C; Brambilla E
    Histopathology; 2009 Jan; 54(1):43-54. PubMed ID: 19187179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene-promoter hypermethylation as a biomarker in lung cancer.
    Belinsky SA
    Nat Rev Cancer; 2004 Sep; 4(9):707-17. PubMed ID: 15343277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of circulating cancer cells in lung cancer patients with a panel of marker genes.
    Liu L; Liao GQ; He P; Zhu H; Liu PH; Qu YM; Song XM; Xu QW; Gao Q; Zhang Y; Chen WF; Yin YH
    Biochem Biophys Res Commun; 2008 Aug; 372(4):756-60. PubMed ID: 18514066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nuclear factor-kappaB (NF-kappaB) is frequently expressed in lung cancer and preneoplastic lesions.
    Tang X; Liu D; Shishodia S; Ozburn N; Behrens C; Lee JJ; Hong WK; Aggarwal BB; Wistuba II
    Cancer; 2006 Dec; 107(11):2637-46. PubMed ID: 17078054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular alterations associated with bladder cancer initiation and progression.
    Cordon-Cardo C
    Scand J Urol Nephrol Suppl; 2008 Sep; (218):154-65. PubMed ID: 18815930
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retinoic acid receptor and retinoid X receptor alterations in lung cancer precursor lesions.
    Martinet N; Alla F; Farré G; Labib T; Drouot H; Vidili R; Picard E; Gaube MP; Le Faou D; Siat J; Borelly J; Vermylen P; Bazarbachi T; Vignaud JM; Martinet Y
    Cancer Res; 2000 Jun; 60(11):2869-75. PubMed ID: 10850430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new tumor suppressor gene: invasion, metastasis, and angiogenesis as potential key targets.
    Albini A; Pfeffer U
    J Natl Cancer Inst; 2006 Jun; 98(12):800-1. PubMed ID: 16788148
    [No Abstract]   [Full Text] [Related]  

  • 39. [Etiology, epidemiology, biology. Lung carcinogenesis].
    Mascaux C
    Rev Mal Respir; 2008 Oct; 25(8 Pt 2):3S32-9. PubMed ID: 18971824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Atypical proliferations and precancerous conditions of the bronchial epithelium and lung cancer].
    Nikulin A; Plamenac P
    Med Arh; 1968; 22(3):5-18. PubMed ID: 5191768
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.